05012025
Last update: 04/29/2025 9:04

Proyecto público-privado para desarrollar una terapia contra la aterosclerosis

El objetivo es validar una nueva familia de candidatos a fármacos para el tratamiento de la acumulación vascular de colesterol asociada a la aterosclerosis. Está liderado por la biotecnológica Iproteos, con sede en el Parc Científic de Barcelona, y participan el Instituto de Investigaciones Biomédicas de Barcelona (IIBB) del CSIC y el Centro de Regulación Genómica (CRG) de Barcelona.

Molecules activated by light

The molecules that change their form when they receive light have opened the door to the so called photo-activated drugs. The change of structure makes them bind together and recognize biological receptors and, therefore, to activate or deactivate them. At the CSIC’s Institute of Advanced Chemistry, scientists are working to develop these types of molecules which can be applied to biomedicine.

Chaos as a strategy

A study analyzes the search strategy for food used by a marine snail. It is based on chaotic turns and movements. This search pattern, could be useful for search applications (drons, people rescue…) when there is no clear sign of the item that has to be found.

A novel targeted anticancer therapy system based on carbon nanocapsules

Researchers from the Materials Science Institute of Barcelona (ICMAB-CSIC) in collaboration with the Catalan Institute of Nanoscience and Nanotechnology (ICN2), the Institute of Molecular and Cellular Biology (IBMC-CNRS) and King’s College London (KCL) have developed a novel nanocarrier anti-cancer platform for the targeted delivery of radioactivity.

Award for the bioreactor that simulates the liver

The project "Liver on a chip", participated by the Biomedical Applications Group of the IMB-CNM (CSIC), won the second prize of the second Vall d’Hebron Research Institute (VHIR) Health Innovation Contest in the Biomedical Research Innovation category.

Four CSIC scientists, awarded in the Llavor program for the creation of technology start-up companies

It is the first edition of the Llavor program, which is aimed at promoting the creation of new technological companies. Four CSIC scientists lead four of the 24 awarded projects.

Hearten, an app to help in the treatment of heart failure

Hearten is a project funded by the European Commission aimed at developing devices and apps for tablets and mobile phones, in order to help heart failure patients and sanitarian professionals to improve adherence to therapy.

Molecule successful in treating Alzheimer's disease in mice

Researchers at the Universitat Autònoma de Barcelona (UAB), the Spanish National Research Council (CSIC) and the University of Barcelona (UB) have successfully tested the ASS234 molecule in transgenic mice models of Alzheimer's diseases.

First partial sequence of an ancient pig genome

A team of Spanish researchers has obtained the first partial genome sequence of an ancient pig. Extracted from a sixteenth century pig found at the site of the Montsoriu Castle in Girona, the obtained data indicates that this ancient pig is closely related to today's Iberian pig. Researchers also discard the hypothesis that Asian pigs were crossed with modern Iberian pigs.